Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

03 November 1997

Clinical importnace of the isotype of anticariolipin antibodies in patients with connective tissue diseases

Lidia Ostanek, Irena Fiedorowicz-Fabrycy

Med Sci Monit 1997; 3(6): CR835-839 :: ID: 501794

Abstract

The purpose of this work was to evaluate the frequency of occurrence of high anticardiolipinic antibody titre (aCL) class IgG and IgM in patients with different systemic connective tissue diseases and determination of the relationship between chosen clinical symptoms and isotype of existing antibodies. 132 patients, including 119 women and 13 men at the age of 20-74 (average age 49.8), with different systemic connective tissue diseases, were examined. Anticardiolipinic antibodies were marked with the use of ELISA method with the application of tests produced by SIGMA. High titres of aCL were found in 35 examined patients (26.5%), in that number 18 (13.6%) were high values of aCL from IgG class, in 11 (9.3%) of aCL from IgM class and in 6 (4.5%) high titres of aCL of both classes (IgG+IgM) Secondary antiphospolipidic anatomosis was diagnosed in 23 patients according to Harris criteria. Skin changes were the most common clinical symptoms and were diagnosed in 17 patients with high titre of aCL. Neurological disturbances were observed in 12 patients, cardiological complications - in 10, thrombosis - in 5. Obstetrical failure occurred in 9 patients. In 23 patients thrombocytopenia occurred, in 10 - leucopenia, in 10 - APTT elongation, in 8 - presence of lupous anticoagulant and in 3 - false positive Wasserman's reactions. Most clinical symptoms, as well as deviations in immunological and haematological examinations, correlated with high class IgG aCL titres.

Keywords: anticardiolipinic antibodies, systemic connective tissue diseases, isotypes IgG and IgM of anticardiolipinic antibodies

Add Comment 0 Comments

452 0

Editorial

01 May 2023 : Editorial  

Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.940911

Med Sci Monit 2023; 29:e940911

In Press

30 May 2023 : Database Analysis  

The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940904  

30 May 2023 : Clinical Research  

Analgesic Efficacy of Combined Thoracic Paravertebral Block and Erector Spinae Plane Block for Video-Assist...

Med Sci Monit In Press; DOI: 10.12659/MSM.940247  

30 May 2023 : Review article  

A Review of the Mechanism of Action and Clinical Applications of Osmotic Dilators for Cervical Ripening in ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940127  

28 May 2023 : Database Analysis  

Scientometric and Visualized Analysis of Intravoxel Incoherent Motion Magnetic Resonance Imaging: 1988-2021

Med Sci Monit In Press; DOI: 10.12659/MSM.938715  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750